NCT00708448 Early Prediction of Therapeutic Response to Targeted Therapy in Stage IIIB/IV or Recurrent Lung Cancer Patients Status COMPLETED Phase PHASE1
NCT00707343 [F-18] Fluorothymidine (FLT) Imaging on Patients With Primary Brain Tumors Status COMPLETED Phase PHASE1
NCT00707278 Radiation Therapy and Capecitabine/Oxaliplatin Chemotherapy in the Treatment of Locally Advanced Pancreas Adenocarcinoma Status COMPLETED Phase PHASE1
NCT00707213 FDG-Positron Emission Tomography (PET)/CT In the Evaluation of Persistent Febrile Neutropenia in Cancer Patients Status TERMINATED Phase PHASE1
NCT00707174 Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna Status COMPLETED Phase NA
NCT00707161 Radiation Therapy and Concurrent Cisplatin Chemotherapy for Locally Advanced or Metastatic Malignant Melanoma Status TERMINATED Phase PHASE2
NCT00706810 Combination of Hydroxyurea and Verapamil for Refractory Meningiomas Status COMPLETED Phase PHASE2
NCT00706199 The Expression of Antigens in Bone Marrow Samples From Volunteering Donors. Status COMPLETED Phase N/A
NCT00706095 Study Of Eribulin (E7389) In Patients With Advanced Solid Tumors And Normal Or Reduced Hepatic Function As Per Child-Pugh System Status COMPLETED Phase PHASE1
NCT00705874 Study of CGC-11047 When Used in Individual Combinations With 1) Gemcitabine or 2) Docetaxel or 3) Bevacizumab or 4) Erlotinib or 5) Cisplatin or 6) 5-Flurouracil or 7) Sunitinib in Patients With Advanced Solid Tumors or Lymphoma Status COMPLETED Phase PHASE1
NCT00705653 Study of CGC-11047 (PG-11047) in Subjects With Advanced Refractory Solid Tumors Status COMPLETED Phase PHASE1
NCT00704392 Safety Study of XL647 and XL147 Administered in Combination Daily in Adults With Solid Tumors Status WITHDRAWN Phase PHASE1
NCT00703976 Radiation, Cetuximab and Pemetrexed With or Without Bevacizumab in Locally Advanced Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00694382 Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy Status COMPLETED Phase PHASE3
NCT00692640 Safety Study of XL147 (SAR245408) in Combination With Erlotinib in Adults With Solid Tumors Status COMPLETED Phase PHASE1